TORONTO–( BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares commence trading on the OTCQB® Venture Market (the “OTCQB”) on March 8, 2021, under the symbol “CLXPF.” The OTCQB, operated by OTC Markets Group Inc., is designed for developing and entrepreneurial…
